Helix BioMedix Inc:企業の戦略的SWOT分析

【英語タイトル】Helix BioMedix Inc - Strategic SWOT Analysis Review

GlobalDataが出版した調査資料(DATA904C0600)・商品コード:DATA904C0600
・発行会社(調査会社):GlobalData
・発行日:2018年7月
・ページ数:24
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Helix BioMedix Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Helix BioMedix Inc (Helix BioMedix) develops an extensive proprietary library of structurally diverse bioactive peptides for the applications in consumer skin care products and prescription products. Its peptides are used in cosmetics, anti-aging skin care products, acne treatment, wound healing and other topical anti-infective treatments. The company is also developing drug candidate peptides for acne, methicillin-resistant staphylococcus aureus (MRSA) and other dermatological conditions. Helix BioMedix partners with contract research organizations, fine ingredient suppliers and manufacturers. It offers its products through its distribution partners. Helix BioMedix is headquartered in Bothell, Washington, the US.

Helix BioMedix Inc Key Recent Developments

Jul 24,2017: EverlyWell Partners with Helix to Launch New Suite of DNA Tests to Provide Deeper Insights about Health and Wellness
Jul 10,2017: Helix BioMedix Promotes Robin L. Carmichael to Chief Executive Officer
Jul 10,2017: Helix CLIA-Certified DNA Sequencing Laboratory Receives College of American Pathologists Accreditation

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Helix BioMedix Inc – Key Facts 5
Helix BioMedix Inc – Key Employees 6
Helix BioMedix Inc – Key Employee Biographies 7
Helix BioMedix Inc – Major Products and Services 8
Helix BioMedix Inc – History 9
Helix BioMedix Inc – Locations And Subsidiaries 10
Head Office 10
Section 2 – Company Analysis 11
Company Overview 11
Helix BioMedix Inc – Business Description 12
Helix BioMedix Inc – SWOT Analysis 13
SWOT Analysis – Overview 13
Helix BioMedix Inc – Strengths 13
Helix BioMedix Inc – Weaknesses 14
Helix BioMedix Inc – Opportunities 15
Helix BioMedix Inc – Threats 16
Helix BioMedix Inc – Key Competitors 17
Section 3 – Company’s Lifesciences Financial Deals and Alliances 18
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 18
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 19
Helix BioMedix Inc, Recent Deals Summary 20
Section 4 – Company’s Recent Developments 21
Jul 24, 2017: EverlyWell Partners with Helix to Launch New Suite of DNA Tests to Provide Deeper Insights about Health and Wellness 21
Jul 10, 2017: Helix BioMedix Promotes Robin L. Carmichael to Chief Executive Officer 22
Jul 10, 2017: Helix CLIA-Certified DNA Sequencing Laboratory Receives College of American Pathologists Accreditation 23
Section 5 – Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Helix BioMedix Inc, Key Facts 5
Helix BioMedix Inc, Key Employees 6
Helix BioMedix Inc, Key Employee Biographies 7
Helix BioMedix Inc, Major Products and Services 8
Helix BioMedix Inc, History 9
Helix BioMedix Inc, Key Competitors 17
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 18
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 19
Helix BioMedix Inc, Recent Deals Summary 20

List of Figures
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 18
Helix BioMedix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 19

★調査レポート[Helix BioMedix Inc:企業の戦略的SWOT分析] (コード:DATA904C0600)販売に関する免責事項を必ずご確認ください。
★調査レポート[Helix BioMedix Inc:企業の戦略的SWOT分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆